Adaptin Bio (APTN) Retained Earnings (2022 - 2026)

Adaptin Bio has disclosed Retained Earnings across 5 years of filings, most recently posting -$10.4 million for Q1 2026.

• Quarterly Retained Earnings fell 120.8% year-over-year to -$10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.4 million (down 120.8% YoY) and the FY2025 annual result came in at -$9.3 million, down 125.3% from the prior year.
• Retained Earnings retreated to -$10.4 million in Q1 2026, from -$9.3 million in the prior quarter.
• Across five years, Retained Earnings topped out at -$27804.0 in Q4 2022 and bottomed at -$10.4 million in Q1 2026.
• The 5-year median for Retained Earnings is -$2.2 million (2024), against an average of -$3.6 million.
• Year-over-year, Retained Earnings plunged 3536.99% in 2024 and sank 120.8% in 2026.
• Adaptin Bio's Retained Earnings stood at -$27804.0 in 2022, then plunged by 307.84% to -$113397.0 in 2023, then plunged by 3536.99% to -$4.1 million in 2024, then plunged by 125.3% to -$9.3 million in 2025, then slipped by 12.33% to -$10.4 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$10.4 million, -$9.3 million, and -$7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.